Royalty Pharma stock forecast
Royalty Pharma (RPRXN) Stock Forecast & Price Target
RPRXN Analyst Ratings
RPRXN Stock 12 Month Forecast
Average Price Target
Mex$1,323▲(9.05% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | Mex$1,311→Mex$1,461 | buy | 20.37%Upside | Reiterated | 11/05/26 | ||
| Terence Flynn | Morgan Stanley | Mex$1,255→Mex$1,404 | buy | 15.74%Upside | Assigned | 11/05/26 | ||
| Chris Schott | J.P. Morgan | Mex$1,161→Mex$1,386 | buy | 14.19%Upside | Reiterated | 11/04/26 | ||
| Jason Gerberry | Bank of America Securities | Mex$1,180 | buy | -2.78%Downside | Reiterated | 10/09/26 | ||
| Ashwani Verma | UBS | Mex$1,236 | buy | 1.85%Upside | Assigned | 09/08/26 | ||
| Michael Nedelcovych | TD Cowen | Mex$1,217→Mex$1,273 | buy | 4.94%Upside | Assigned | 09/08/26 | ||
| Asad Haider | Goldman Sachs | Mex$1,105→Mex$1,236 | buy | 1.85%Upside | Reiterated | 08/06/26 | ||
| Umer Raffat | Evercore ISI | ― | hold | ― | Reiterated | 02/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Geoff MeachamCiti | BuyReiteratedMex$1,311→Mex$1,461 | 11/05/26 | 20.37%Upside | ||
| Terence FlynnMorgan Stanley | BuyAssignedMex$1,255→Mex$1,404 | 11/05/26 | 15.74%Upside | ||
| Chris SchottJ.P. Morgan | BuyReiteratedMex$1,161→Mex$1,386 | 11/04/26 | 14.19%Upside | ||
| Jason GerberryBank of America Securities | BuyReiteratedMex$1,180 | 10/09/26 | -2.78%Downside | ||
| Ashwani VermaUBS | BuyAssignedMex$1,236 | 09/08/26 | 1.85%Upside | ||
| Michael NedelcovychTD Cowen | BuyAssignedMex$1,217→Mex$1,273 | 09/08/26 | 4.94%Upside | ||
| Asad HaiderGoldman Sachs | BuyReiteratedMex$1,105→Mex$1,236 | 08/06/26 | 1.85%Upside | ||
| Umer RaffatEvercore ISI | HoldReiterated | 02/12/26 | ― |
Best Analysts Covering Royalty Pharma
Copying Geoff Meacham's trades and holding each position for 3 Months would result in 72.00% of your transactions generating a profit, with an average return of +5.50% per trade.
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 68.00% of your transactions generating a profit, with an average return of +21.37% per trade.
Copying Geoff Meacham's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +50.05% per trade.
RPRXN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 8 | 13 | 13 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 8 | 13 | 13 | 11 |
In the current month, RPRXN has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RPRXN average Analyst price target in the past 3 months is 1,323.35.
RPRXN Financial Forecast
RPRXN Earnings Forecast
Next quarter’s earnings estimate for RPRXN is MXN 29.13 with a range of MXN 27.71 to MXN 30.49. The previous quarter’s EPS was MXN 22.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RPRXN Sales Forecast
Next quarter’s sales forecast for RPRXN is MXN 17.87B with a range of MXN 17.02B to MXN 18.36B. The previous quarter’s sales results were MXN 12.84B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
